Inhaled Indomethacin-Loaded Liposomes as Potential Therapeutics against Non-Small Cell Lung Cancer (NSCLC)-Reference-Cited by-同舟云学术

Inhaled Indomethacin-Loaded Liposomes as Potential Therapeutics against Non-Small Cell Lung Cancer (NSCLC)

Published:2022-09-15 Issue:11 Volume:39 Page:2801-2815
ISSN:0724-8741
Container-title:Pharmaceutical Research
language:en
Short-container-title:Pharm Res

Author:

Sarvepalli Sruthi,Parvathaneni Vineela,Chauhan Gautam,Shukla Snehal K.,Gupta Vivek^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology

Link

https://link.springer.com/content/pdf/10.1007/s11095-022-03392-x.pdf

Reference87 articles.

1. Zappa C, Mousa SA. Non-small cell lung cancer: current treatment and future advances. Transl Lung Cancer Res. 2016 Jun;5(3):288–300.

2. Arbour KC, Riely GJ. Systemic Therapy for Locally Advanced and Metastatic Non-Small Cell Lung Cancer: A Review. JAMA. 2019 Aug 27;322(8):764–74.

3. Lung Cancer Survival Rates | 5-Year Survival Rates for Lung Cancer [Internet]. [cited 2021 Jul 9]. Available from: https://www.cancer.org/cancer/lung-cancer/detection-diagnosis-staging/survival-rates.html

4. Lin C, Wong BCK, Chen H, Bian Z, Zhang G, Zhang X, et al. Pulmonary delivery of triptolide-loaded liposomes decorated with anti-carbonic anhydrase IX antibody for lung cancer therapy. Sci Rep. 2017 Apr 20;7(1):1–12.

5. Lung Cancer 101 | Lungcancer.org [Internet]. [cited 2020 Mar 7]. Available from: https://www.lungcancer.org/find_information/publications/163-lung_cancer_101/271-treatment_side_effects

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Material and Design Toolkit for Drug Delivery: State of the Art, Trends, and Challenges;ACS Applied Materials & Interfaces;2023-11-23

2. Nanotechnology boosts the efficiency of tumor diagnosis and therapy;Frontiers in Bioengineering and Biotechnology;2023-07-28

3. Natural fulvic acids inhibit non-small-cell lung cancer through the COX-2/PGE2/EP4 axis: In silico and in vivo assessments;Heliyon;2023-06

4. Nano-mediated strategy for targeting and treatment of non-small cell lung cancer (NSCLC);Naunyn-Schmiedeberg's Archives of Pharmacology;2023-05-23

5. Lipid-Based Inhalable Micro- and Nanocarriers of Active Agents for Treating Non-Small-Cell Lung Cancer;Pharmaceutics;2023-05-10